Skip to main content
  • Original Article
  • Published:

Advocacy, promotion and e-learning: Supercourse for zoonosis

Abstract

This paper discusses the history of emerging infectious diseases, risk communication and perception, and the Supercourse lectures as means to strengthen the concepts and definition of risk management and global governance of zoonosis. The paper begins by outlining some of the key themes and issues in infectious diseases, highlighting the way which historical analysis challenges ideas of the ‘newness’ of some of these developments. It then discusses the role of risk communication to public accountability. The bulk of the paper presents an overview of developments of the Internet-based learning system through the Supercourse lectures that may prove to be a strong arm for the promotion of the latest medical information particularly to developing countries.

References

  1. Lederberg J, Shope RE, Oaks SC editors. Emerging Infections; Microbial Threats in the United States. Washington, DC, USA; 1992; 312.

    Google Scholar 

  2. World Health Organization. Removing Obstacles to Healthy Development. Genéve Switzerland; 1999; 68.

  3. Kindhauser MK editor. Global Defence against the Infectious Disease Threat. World Health Organization. Geneve, Switzerland; 2003; 242.

    Google Scholar 

  4. Linkov F, Shubnikov E, Husseini AS, Lovalekar M, LaPorte R. Globalisation of prevention education: a golden lecture. Lancet. 2003; 362: 1586–1587.

    Article  PubMed  Google Scholar 

  5. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis. 1995;1:7–15.

    PubMed  CAS  Google Scholar 

  6. World Health Organization. The World Health Report. World Health Organization: Geneve, Switzerland; 2004.

    Google Scholar 

  7. Guerrant RL, Blackwood BL. Threats to global health and survival; the growing crises of tropical infectious diseases— an unfinished agenda. Clin Infect Dis. 1999;28:966–986.

    Article  PubMed  CAS  Google Scholar 

  8. Butler JC, Crengle S, O’Brien KL, Santosham M, Cheek JE, Leach AJ, et al., Emerging infectious diseases among indigenous peoples. Emerg Infect Dis. 2001;7(suppl):554–555.

    PubMed  CAS  Google Scholar 

  9. Morens DM, Littman RJ. Epidemiology of the plague of Athens. Trans Am Philol Assoc. 1992;122:271–304.

    Google Scholar 

  10. Crosby AW. In: The Columbian Exchange: Biological and Cultural Consequences of 1492. Greenwood, Westport: Connecticut; 1972.

  11. Hopkins, D. In: Princes and Peasants. Smallpox in History. Chicago: Univ. Chicago Press: 1983. p. 204–233.

    Google Scholar 

  12. Koch R. Untersuchungen über bacterien. V. Die aetiologie der Milzbrand-Krankheit, begründet auf die Entwicklungsgeschichte des Bacillus anthracis. Beiträge zur Biologie der Pflanze. 1876;2:277–310.

    Google Scholar 

  13. Worboys M, Spreading Germs: Diseases, Theories, and Medical Practice in Britain, 1865–1900. Cambridge: Cambridge Univ. Press: 2000.

    Google Scholar 

  14. Porter R. The Greatest Benefit to Mankind: A Medical History of Humanity from Antiquity to the Present. London: W. W. Norton and Co.; 1997.

    Google Scholar 

  15. Cockburn A. The Evolution and Eradication of Infectious Diseases. Baltimore: Johns Hopkins Univ. Press, Baltimore; 1963.

    Google Scholar 

  16. Fauci AS. Infectious diseases: considerations for the 21st century. Clin Infect Dis. 2001;32:675–685.

    Article  PubMed  CAS  Google Scholar 

  17. Committee on Emerging Microbial Threats to Health. In: Lederberg J, Shope RE, Oaks SC editors. Emerg Infect. Microbial Threats to Health in the United States. Washington, DC: National Academy Press; 1992.

    Google Scholar 

  18. Committee on Emerging Microbial Threats to Health in the 21st Century. In: Smolinski MS, Hamburg MA, Lederberg J editors. Microbial Threats to Health in the United States: Emergence, Detection and Response. Washington, DC: National Academy Press: 2003.

    Google Scholar 

  19. Stephens DS, Moxon ER, Adams J, Altizer S, Antonovies J, Aral S, et al., Emerging and re-emerging infectious diseases: a multidisciplinary perspective. Am J Med Sci. 1998;315:64–75.

    Article  PubMed  CAS  Google Scholar 

  20. Desselberger U. Emerging and re-emerging infectious diseases. J Infect. 2000;40:3–15.

    Article  PubMed  CAS  Google Scholar 

  21. Lederberg J. Infectious history. Science. 2000;288:287–293.

    Article  PubMed  CAS  Google Scholar 

  22. Pollard A, Dobson AR. Emerging infectous diseases in the 21 st century. Curr Opin Infect Dis. 2000;13:265–275.

    PubMed  Google Scholar 

  23. Feldman H, Czub M, Jones S, Dick D, Garbutt M, Grolla A, et al. Emerging and re-emerging infectious diseases. Med Microbiol Immunol. 2002;191:63–74.

    Article  Google Scholar 

  24. Sharp PM, et al. The origins of acquired immune deficiency viruses: where and when? Phil Trans R Soc Lond B. 2001; 356:867–876.

    Article  CAS  Google Scholar 

  25. Quinn TC. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc. Natl. Acad. Sci U S A. 1994;91:2407–2414.

    Article  PubMed  CAS  Google Scholar 

  26. Daley CL, et al. The AIDS Knowledge Base 3rd ed. Cohen PT, Sande MA, Volberding PA editors. Philadelphia: Lippincott, Williams and Wilkins; 1999. p. 23–52.

    Google Scholar 

  27. Ronald AR. Slowing heterosexual HIV transmission. Infect Dis Clin North Am. 1995;9:287–296.

    PubMed  CAS  Google Scholar 

  28. Beisel CD, Morens DM. Variant Creutzfeldt-Jakob disease and the acquired and transmissible spongiform encephalopathies. Clin Infect Dis. 2004;38:697–704.

    Article  PubMed  Google Scholar 

  29. Katz AR, Morens DM, Severe streptococcal infections in historical perspective. Clin Infect Dis. 1992;14:298–307.

    PubMed  CAS  Google Scholar 

  30. Musser JM, Krause RM. Emerging infections. In: Krause RM editor. Biomedical Research Reports San Diego: Academic Press; 1998. p. 185–218.

    Google Scholar 

  31. Reid SD, Hoe NP, Smoot LM, Musser JM. Group A streptococcus: allelic variation, population genetics, and hostpathogen interactions. J Clin Invest. 2001;107:393–399.

    Article  PubMed  CAS  Google Scholar 

  32. Beres SB, et al. Genome sequence of a serotype M3 strain of Group A Streptococcus: phage-encoded toxins, the highvirulence phenotype, and clone emergence. Proc Natl Acad Sci U S A. 2003;99:10078–10083.

    Article  CAS  Google Scholar 

  33. Chang Y, et al. Identification if herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–1869.

    Article  PubMed  CAS  Google Scholar 

  34. Parsonnet J editor. Microbes and Malignancy: Infection as a Cause of Human Cancers. New York: Oxford Univ. Press, 1999.

    Google Scholar 

  35. Sanders MK, Peura DA.Helicobacter pylori-associated diseases. Curr Gastroenterol Rep. 2002;4:448–454.

    Article  PubMed  Google Scholar 

  36. Fredericks DN, Relman DA. Current clinical topics in infectious diseases. In: Remington JS, Swartz MN editors. Massachusetts: Blackwell Science; 1998. p. 180–200.

    Google Scholar 

  37. Kovats RS, Bouma MJ, Hajat S, Worrall E and Haines A. El Niño and health. Lancet. 2003;362:1481–1489.

    Article  PubMed  Google Scholar 

  38. Cliff A, Haggett P, Smallman-Raynor M. In: Island Epidemics. Oxford: Oxford Univ. Press; 2000. p. 165–236.

    Google Scholar 

  39. Massey A. Epidemiology in Relation to Air Travel. London: HK Lewis and Co.; 1993.

    Google Scholar 

  40. Morens DM. Acute hemorrhagic conjunctivitis: dealing with a newly emerging disease. Pae Health Dialog. 1998;5:147–153.

    Google Scholar 

  41. Peiris JSM, Yuen KY, Osterhaus ADME, Stör K. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431–2441.

    Article  PubMed  CAS  Google Scholar 

  42. Wellems TE, Miller LH. Two worlds of malaria. N Engl J Med. 2003;349:1496–1498.

    Article  PubMed  CAS  Google Scholar 

  43. Miller LH, Hoffman SL. Research toward vaccines against malaria. Nature Med. 1998;4(suppl):520–524.

    Article  PubMed  CAS  Google Scholar 

  44. Espinal MA. The global situation of MDR-TB. Tuberculosis. 2003;83:44–51.

    Article  PubMed  Google Scholar 

  45. Lee JH. Methicillin (oxacillin)-resistantStaphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl Environ Microbiol. 2003;69:6489–6494.

    Article  PubMed  CAS  Google Scholar 

  46. Centers for Disease Control Prevention.Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR. 2002;51:565–567.

    Google Scholar 

  47. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 2003. UNAIDS: Genève; 2003.

    Google Scholar 

  48. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992–1997. MMWR 48. CDC Surveillance Summary no. SS-2. 1999;1–22.

  49. Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807–1814.

    Article  PubMed  CAS  Google Scholar 

  50. Platonov AE, Shipulin GA, Shipulina OY, Platonova OV, Pokrovskii VI, Tyutyunnik EN, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001;7:128–132.

    PubMed  CAS  Google Scholar 

  51. Komar N. West Nile virus: epidemiology and ecology in North America. Adv Virus Res. 2003;61:185–234.

    Article  PubMed  Google Scholar 

  52. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480–497.

    PubMed  CAS  Google Scholar 

  53. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis. 1994;19:500–512.

    PubMed  CAS  Google Scholar 

  54. Faruque SM, Nair GB. Molecular ecology of toxigenicVibrio cholerae. Microbiol Immunol. 2002;46:59–60.

    PubMed  CAS  Google Scholar 

  55. Shortridge KF, Peiris JS, Guan Y. The next influenza pandemic: lessons from Hong Kong. J Appl Microbiol. 2003; 94:70S-79S.

    Article  PubMed  Google Scholar 

  56. Webster RG. A molecular whodunit. Science. 2001;293: 1773–1775.

    PubMed  CAS  Google Scholar 

  57. Alibek K, Handelman S. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World Told from the Inside by the Man who Ran It. New York: Random House: 1999.

    Google Scholar 

  58. Török TJ, Tauxe RV, Wise RP, Livengood JR, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. J Am Med Assoc. 1997;278:389–395.

    Article  Google Scholar 

  59. Jernigan DB, Ragnuhathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019–1028.

    PubMed  Google Scholar 

  60. Miami Herald. Report. Japanese sect was close to bioterrorism journal says: Live anthrax found at office. 2001 Aug 30. [cited 2005 Feb 20]. Available at: URL: http://www.rickross.com/reference/aum/aum270.html

  61. Darling RG, Catlett CL, Huebner KD, Jarrett DG, Threats in bioterrorism: I. CDC category A agents. Emerg Med Clin North Am. 2002;20:273–309.

    Google Scholar 

  62. Ropeik D, Gray G. Risk: A, Practical Guide for Deciding What’s Really Safe and What’s Really, Dangerous in the World around You. New York, NY: Houghton Mifflin Co; 2002.

    Google Scholar 

  63. World Health Organization. The application of risk communication to food standards and safety matters, a joint FAO/WHO expert consultation. Rome, Italy. 1998 Feb 2–6 [cited 2004 Dec 16]. Available from: URL: http://www.who.int/foodsafety/publications/micro/feb1998/cn/

  64. Fischoff B, Lichtenstein S, Slovic P, Keeney D. Acceptable Risk. Cambridge, Massachusetts: Cambridge University Press: 1981.

    Google Scholar 

  65. Supercourse: epidemiology, the Internet, and global health. [cited 2004 Dec 19]. Available from: URL: http://www.pitt.edu/-super1/

  66. Supercourse Japan website. [cited 2004 Dec 19]. Available from: URL: http://www.supercourse-japan.org/

  67. Covello V, Allen F. Seven Cardinal Rules of Risk Communication. US Environmental Protection Agency. Office of Policy Analysis. Washington, DC; 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiko Tamashiro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matibag, G.C., Igarashi, M., La Porte, R.E. et al. Advocacy, promotion and e-learning: Supercourse for zoonosis. Environ Health Prev Med 10, 273–281 (2005). https://doi.org/10.1007/BF02897702

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02897702

Key words